Luminex Profit Margin

Luminex (LMNX) currently reports a profit margin of 5.29% as of March 2021. That compares with -1.76% in the prior-year period — up 399.8% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Luminex's profit margin history and peer comparisons.

Luminex's profit margin increased from -1.76% to 5.29% — a 399.8% year-over-year increase (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Luminex's profit margin of 5.29% is lower than the Healthcare sector average of 14.34%. That is roughly 63.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Luminex's current 5.29% should be judged against Healthcare norms (sector average: 14.34%) and against LMNX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 5.29%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Luminex, and consider following LMNX for alerts when major investors trade the stock.